요약정보
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
- Resource Type
- Academic Journal
- Authors
- Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Reveal Genomics, Barcelona, Spain. alprat@clinic.cat.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. alprat@clinic.cat.; Department of Medicine, University of Barcelona, Barcelona, Spain. alprat@clinic.cat.; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain. alprat@clinic.cat.; SOLTI cooperative group, Barcelona, Spain. alprat@clinic.cat.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain.; Xia Y; Reveal Genomics, Barcelona, Spain.; Bellet M; SOLTI cooperative group, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Martínez D; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; SOLTI cooperative group, Barcelona, Spain.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.; Marín-Aguilera M; Reveal Genomics, Barcelona, Spain.; Rodríguez A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Chic N; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Vidal M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Margelí M; Department of Medical Oncology, Institut Catalan of Oncology - Badalona, Hospital Germans Trias i Pujol, Badalona, Spain.; Ballana E; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Badalona, Spain.; Gómez-Rey M; Cancer Genomics Group, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oliveira M; SOLTI cooperative group, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Felip E; Department of Medical Oncology, Institut Catalan of Oncology - Badalona, Hospital Germans Trias i Pujol, Badalona, Spain.; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Badalona, Spain.; Matito J; Cancer Genomics Group, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Sánchez-Bayona R; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Suñol A; Department of Medical Oncology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Saura C; SOLTI cooperative group, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ciruelos E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Tolosa P; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; SOLTI cooperative group, Barcelona, Spain.; González-Farré B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; Parker JS; Department of Genetics, University of North Carolina, Chapel Hill, USA.; Perou CM; Department of Genetics, University of North Carolina, Chapel Hill, USA.; Vivancos A; Cancer Genomics Group, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.
- Source
- Publisher:
Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN:20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE - Subject
- Language
- English